日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aza-peptide aldehydes and ketones: synthesis and evaluation as human 20S proteasome inhibitors

氮杂肽醛和酮:合成及作为人20S蛋白酶体抑制剂的评价

Corrigan, Thomas S; Border, Sarah E; Lotti Diaz, Leilani M; Kasper, Kayla Q; Noonchester, Abigail M; Amer, Rasmiah; Kucway, Kayla S; Fleisher, Michael; Fernandez, Joseph P; Lovins, Alex R; Serrano, Ana K; Caffrey, Conor R; O'Donoghue, Anthony J; Benson, Don M Jr; Hadad, Christopher M; Ekici, Özlem Doğan

Long-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple Myeloma

CALGB(联盟)100001 研究的长期随访:自体移植后序贯非清髓性异基因移植治疗多发性骨髓瘤

Holstein, Sarah A; Suman, Vera J; Owzar, Kouros; Santo, Katelyn; Benson, Don M Jr; Shea, Thomas C; Martin, Thomas; Silverman, Margarida; Isola, Luis; Vij, Ravi; Cheson, Bruce D; Linker, Charles; Anderson, Kenneth C; Richardson, Paul G; McCarthy, Philip L

A CS1-NKG2D Bispecific Antibody Collectively Activates Cytolytic Immune Cells against Multiple Myeloma.

CS1-NKG2D双特异性抗体共同激活细胞毒性免疫细胞对抗多发性骨髓瘤

Chan Wing Keung, Kang Siwen, Youssef Youssef, Glankler Erin N, Barrett Emma R, Carter Alex M, Ahmed Elshafa H, Prasad Aman, Chen Luxi, Zhang Jianying, Benson Don M Jr, Caligiuri Michael A, Yu Jianhua

Checkpoint inhibition in myeloma

多发性骨髓瘤中的检查点抑制

Benson, Don M Jr

The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma

米拉妥珠单抗(一种人源化抗CD74抗体)与维妥珠单抗(一种人源化抗CD20抗体)联合用药,对复发和难治性B细胞非霍奇金淋巴瘤患者显示出疗效。

Christian, Beth A; Poi, Ming; Jones, Jeffrey A; Porcu, Pierluigi; Maddocks, Kami; Flynn, Joseph M; Benson, Don M Jr; Phelps, Mitch A; Wei, Lai; Byrd, John C; Wegener, William A; Goldenberg, David M; Baiocchi, Robert A; Blum, Kristie A

A phase I trial of single-agent reolysin in patients with relapsed multiple myeloma

一项针对复发性多发性骨髓瘤患者的单药瑞奥利辛I期临床试验

Sborov, Douglas W; Nuovo, Gerard J; Stiff, Andrew; Mace, Thomas; Lesinski, Gregory B; Benson, Don M Jr; Efebera, Yvonne A; Rosko, Ashley E; Pichiorri, Flavia; Grever, Michael R; Hofmeister, Craig C

Killer immunoglobulin-like receptors and tumor immunity

杀伤性免疫球蛋白样受体和肿瘤免疫

Benson, Don M Jr; Caligiuri, Michael A

Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808

重组白细胞介素-2治疗60岁以下急性髓系白血病首次完全缓解期患者:来自癌症和白血病B组19808的研究结果

Kolitz, Jonathan E; George, Stephen L; Benson, Don M Jr; Maharry, Kati; Marcucci, Guido; Vij, Ravi; Powell, Bayard L; Allen, Steven L; Deangelo, Daniel J; Shea, Thomas C; Stock, Wendy; Bakan, Courtney E; Hars, Vera; Hoke, Eva; Bloomfield, Clara D; Caligiuri, Michael A; Larson, Richard A

Characterization of multiple myeloma vesicles by label-free relative quantitation

利用无标记相对定量方法对多发性骨髓瘤囊泡进行表征

Harshman, Sean W; Canella, Alessandro; Ciarlariello, Paul D; Rocci, Alberto; Agarwal, Kitty; Smith, Emily M; Talabere, Tiffany; Efebera, Yvonne A; Hofmeister, Craig C; Benson, Don M Jr; Paulaitis, Michael E; Freitas, Michael A; Pichiorri, Flavia

Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma

接受新型疗法治疗的多发性骨髓瘤患者中,早期自体干细胞移植与延迟自体干细胞移植的比较

Dunavin, Neil C; Wei, Lai; Elder, Patrick; Phillips, Gary S; Benson, Don M Jr; Hofmeister, Craig C; Penza, Sam; Greenfield, Carli; Rose, Karen S; Rieser, Gisele; Merritt, Lisa; Ketcham, Jill; Heerema, Nyla; Byrd, John C; Devine, Steven M; Efebera, Yvonne A